This study demonstrated the prognostic implications of tumor-infiltrating MDSCs, PD-1+/CD8+ TIL ratio, and PD-L1 expression in stromal immune cells and tumor cells in patients with locally advanced rectal cancer. The gene discussed is CD8A; the disease is rectal cancer.